Table 3.
Patients’ characteristics distributions between dead and survived patients.
| Variable | Survived n = 39 (88.6%) |
Dead n = 5 (11.4%) |
Total n = 44 (100%) |
p-Value |
|---|---|---|---|---|
| Basal characteristics | ||||
| Gender (Males) | 16 (36.4%) | 1 (2.3%) | 17 (38.6%) | 0.36 |
| Age | 76 ± 13 (SD) | 68 ± 8 (SD) | 79 ± 13 (SD) | 0.06 |
| Clinical characteristics | ||||
| Cardiovascular disease/hypertension | 29 (65.9%) | 3 (6.8%) | 32 (72.7%) | 0.49 |
| Pulmonary disease | 9 (20.5%) | 3 (6.8%) | 12 (27.3%) | 0.08 |
| 4C score | 9.8 ± 2.03 (SD) | 11 ± 1.4 (SD) | 10 ± 2 (SD) | 0.43 |
| CCI | 5.9 ± 1.8 (SD) | 5.5 ± 1.8 (SD) | 6 ± 2 (SD) | 0.57 |
| Vaccination | ||||
| Not vaccinated | 4 (9.1%) | 1 (2.3%) | 5 (11.4%) | 0.51 |
| Vaccinated (Second dose) | 8 (18.2%) | 0 | 8 (18.2%) | 0.26 |
| Vaccinated (Third dose) | 27 (61.4%) | 4 (9.1%) | 31 (70.5%) | 0.61 |
Abbreviations: CCI: Charlson comorbidity index; 4C: four “C” score; SD: standard deviation.